Literature DB >> 9211134

Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.

R G Gheri1, W Boddi, F Ammannati, J Olivotto, C Nozzoli, A Franchi, L Bordi, M L Luisi, P Mennonna.   

Abstract

In this report we describe the case of a young female patient with amenorrhea-galactorrhea syndrome apparently due to pituitary PRL-secreting adenoma who, after three years of dopaminergic therapy without any shrinkage of the tumor, developed true Cushing's disease. Progression from hyperprolactinemia to hypersecretion of ACTH has been rarely described and it may be due to different possibilities. However, histopathological and immunohistochemical studies of the adenoma showed a pattern of PRL negative and ACTH positive cells, excluding mixed pituitary tumor. In order to explain the progression from hyperprolactinemia with amenorrhea-galactorrhea to an ACTH hypersecretion syndrome, it must be hypothesized either pituitary stalk compression or the influence of paracrine regulation factor(s) (such as Galanine) due to an "initially silent" corticotropinoma. This case confirms that the presence of hyperprolactinemia in a patient with pituitary tumor and amenorrhea-galactorrhea syndrome is insufficient to confidently conclude for prolactinoma. Furthermore, it underlines the importance both of clinically monitoring the patient with prolactin pituitary adenoma if dopaminergic therapy does not reduce tumor volume, and of accurately and repeatedly measuring the other pituitary hormonal secretions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9211134     DOI: 10.1007/BF03346911

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  [2 step course of a pituitary adenoma: amenorrhea-galactorrhea syndrome then Cushing's disease].

Authors:  F Berthezene; R Mornex; M Boucher; G Fournier; B Claustrat
Journal:  Rev Otoneuroophtalmol       Date:  1974 May-Jun

2.  Simultaneously occurring prolactinomas. Case report.

Authors:  S K Powers; C B Wilson
Journal:  J Neurosurg       Date:  1981-07       Impact factor: 5.115

3.  Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.

Authors:  D W Hsu; S C Hooi; E T Hedley-Whyte; R M Strauss; L M Kaplan
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

4.  Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.

Authors:  J Li; L Stefaneanu; K Kovacs; E Horvath; H S Smyth
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Hyperprolactinemia in Cushing's disease and Nelson's syndrome.

Authors:  T Yamaji; M Ishibashi; A Teramoto; T Fukushima
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

Review 6.  Management of nonfunctioning pituitary adenomas.

Authors:  G Sassolas; J Trouillas; C Treluyer; G Perrin
Journal:  Acta Endocrinol (Copenh)       Date:  1993-07

7.  Recurrent goiter, hyperthyroidism, galactorrhea and amenorrhea due to a thyrotropin and prolactin-producing pituitary tumor.

Authors:  K Horn; F Erhardt; R Fahlbusch; C R Pickardt; K V Werder; P C Scriba
Journal:  J Clin Endocrinol Metab       Date:  1976-07       Impact factor: 5.958

8.  Enhanced prolactin responsiveness to galanin in patients with Cushing's disease.

Authors:  C Invitti; F Pecori Giraldi; A Tagliaferri; M Scacchi; A Dubini; F Cavagnini
Journal:  Clin Endocrinol (Oxf)       Date:  1993-08       Impact factor: 3.478

9.  Multihormonal response to CRH in a patient with Cushing syndrome and a pituitary adenoma producing ACTH and GH.

Authors:  M J Bugalho; J F Nunes; L G Sobrinho; E Medina; J A Campos; C G da Silva; A L Clode
Journal:  Acta Endocrinol (Copenh)       Date:  1993-03

10.  The treatment of acromegaly by transsphenoidal surgery.

Authors:  H S Tucker; S R Grubb; J P Wigand; C O Watlington; W G Blackard; D P Becker
Journal:  Arch Intern Med       Date:  1980-06
View more
  10 in total

1.  Hyperprolactinemia preceding Cushing's disease.

Authors:  L Barbetta; C Dall'Asta; B Ambrosi
Journal:  J Endocrinol Invest       Date:  2000 Jul-Aug       Impact factor: 4.256

2.  Metamorphosis of a non-functioning pituitary adenoma to Cushing's disease.

Authors:  B Ambrosi; L Barbetta; C Dall'Asta; R Libé
Journal:  Pituitary       Date:  2001-08       Impact factor: 4.107

3.  The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3.

Authors:  Alberto Righi; Marco Faustini-Fustini; Luca Morandi; Valentina Monti; Sofia Asioli; Diego Mazzatenta; Antonella Bacci; Maria Pia Foschini
Journal:  Endocrine       Date:  2016-08-04       Impact factor: 3.633

4.  From macroprolactinoma to concomitant ACTH-PRL hypersecretion with Cushing's disease.

Authors:  M Barausse; R Attanasio; D Dallabonzana; G Oppizzi; S Veronese; G Lasio; L G Valentini; R Cozzi
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

Review 5.  Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.

Authors:  Fabienne Langlois; Dawn Shao Ting Lim; Chris G Yedinak; Isabelle Cetas; Shirley McCartney; Justin Cetas; Aclan Dogan; Maria Fleseriu
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

6.  Metamorphosis of a non-functioning pituitary adenoma to Cushing's disease.

Authors:  E U Tan; M S Ho; C R Rajasoorya
Journal:  Pituitary       Date:  2000-10       Impact factor: 4.107

7.  Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline.

Authors:  G T'Sjoen; I Defeyter; J Van De Saffele; R Rubens; M Vandeweghe
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

8.  Cushing's disease arising from a clinically nonfunctioning pituitary adenoma.

Authors:  Luiz Roberto Salgado; Márcio Carlos Machado; Arthur Cukiert; Bernardo Liberman; Cristina Takami Kanamura; Venancio Avancini Ferreira Alves
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

9.  Composite somatotroph--ACTH-immunoreactive pituitary adenoma with transformation of hyperplasia to adenoma.

Authors:  N Mazarakis; G Kontogeorgos; K Kovacs; E Horvath; N Borboli; G Piaditis
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

10.  Cushing Disease After Treatment of Nonfunctional Pituitary Adenoma: A Case Report and Literature Review.

Authors:  Hongjuan Fang; Rui Tian; Huanwen Wu; Jian Xu; Hong Fan; Jian Zhou; Liyong Zhong
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.